|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 February 2024 |
|
Main ID: |
NCT02771236 |
|
Date of registration:
|
12/05/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Clinical and Molecular Studies in Families With Inherited Eye Disease
|
|
Scientific title:
|
Clinical and Molecular Studies in Families With Inherited Eye Disease |
|
Date of first enrolment:
|
October 4, 2016 |
|
Target sample size:
|
5000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02771236 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
China
|
India
|
Iran, Islamic Republic of
|
Italy
|
Pakistan
|
Philippines
|
Ukraine
|
United Kingdom
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
James F Hejtmancik, M.D. |
|
Address:
|
|
|
Telephone:
|
(301) 435-1598 |
|
Email:
|
f3h@helix.nih.gov |
|
Affiliation:
|
|
|
|
Name:
|
James F Hejtmancik, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Eye Institute (NEI) |
| |
|
Key inclusion & exclusion criteria
|
- INCLUSION CRITERIA:
To be eligible, the following inclusion criteria must be met, where applicable;
1. Participant must be four years of age or older.
2. Participant must understand and sign the protocol s informed consent document.
3. Individuals or family members of individuals with inherited eye diseases, either
congenital, childhood, or age related.
4. All participants must be able to cooperate with study examination and phlebotomy.
EXCLUSION CRITERIA:
A participant is not eligible if any of the following exclusion criteria are present:
1. Participant has a disease, infection, or trauma that mimics inherited cataracts,
retinal degenerations, glaucoma, etc.
2. Participant has a significant active infection (an infection requiring treatment as
determined by the investigator) or a history of chronic or recurrent infections.
3. Participant requires sedation for study purposes.
Age minimum:
4 Years
Age maximum:
120 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Inherited Eye Disease
|
|
Primary Outcome(s)
|
|
Document the clinical and genetic features of Mendelian and age related visual disorders
[Time Frame: Study duration]
|
|
Secondary ID(s)
|
|
160104
|
|
16-EI-0104
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|